CDK 4/6 Inhibitors: Evolution and Revolution in the Management of ER+ Metastatic Breast Cancer.

Reddy, Priyanka M; Martin, James M; Montero, Alberto J

Reddy, Priyanka M; Martin, James M; Montero, Alberto J.

Afiliação

Reddy PM; Division of Hematology and Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH.
Martin JM; Division of Hematology and Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH.
Montero AJ; Division of Hematology and Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH.

JCO Oncol Pract ; 18(5): 329-330, 2022 05.

Article em En | MEDLINE | ID: mdl-34637353

Assuntos

Neoplasias da Mama; Neoplasias da Mama/tratamento farmacológico; Neoplasias da Mama/patologia; Feminino; Humanos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: JCO Oncol Pract Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google